表紙
市場調查報告書

腸道疾病檢驗的全球市場:疾病的種類·各領域的未來預測

Enteric Disease Testing Market Analysis, By Disease Type (Bacterial (C. Difficile, Cholera, E. Coli, H. Pylori, Salmonellosis, Shigellosis), Viral (Rotavirus, Norovirus), Parasitic, And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 557170
出版日期 內容資訊 英文 90 Pages
商品交期: 2-3個工作天內
價格
Back to Top
腸道疾病檢驗的全球市場:疾病的種類·各領域的未來預測 Enteric Disease Testing Market Analysis, By Disease Type (Bacterial (C. Difficile, Cholera, E. Coli, H. Pylori, Salmonellosis, Shigellosis), Viral (Rotavirus, Norovirus), Parasitic, And Segment Forecasts, 2014 - 2025
出版日期: 2017年08月08日內容資訊: 英文 90 Pages
簡介

本報告提供全球腸道疾病檢驗市場相關分析,提供各產品概要和市場基本結構·最新形勢,主要的推動及阻礙市場要素,整體市場規模趨勢預測 (過去3年·今後9年份),疾病的各類型·各地區的詳細趨勢,主要企業簡介·業績等調查。

第1章 分析方法·範圍

第2章 摘要整理

第3章 腸道疾病檢驗市場:產業的未來展望

  • 市場區分
  • 產品普及率·市場成長率預測:製圖
  • 市場動態
    • 推動市場要素分析
    • 阻礙市場要素分析
  • 優先級高的主要市場機會
  • 波特的五力分析
  • PESTEL分析

第4章 腸道疾病檢驗市場:疾病類別的未來展望

  • 疾病類別的市場佔有率 (最新值·預測值)
  • 細菌性腸道疾病市場:市場規模的估計·預測,各疾病
    • 困難腸梭菌 (C. difficile)
    • 曲狀桿菌症
    • 霍亂
    • 大腸菌 (E.Coli)
    • 幽門螺旋桿菌 (H.Pylori)
    • 沙門氏菌症
    • 細菌性赤痢
  • 病毒性腸道疾病市場:市場規模的估計·預測,各疾病
    • 輪狀病毒
    • 諾羅病毒
  • 寄生蟲性腸道疾病市場:市場規模的估計·預測,各疾病
    • 阿米巴赤痢
    • 隱孢子蟲症
    • 腸梨形鞭毛蟲病

第5章 腸道疾病檢驗市場:各地區的未來展望

  • 北美
    • 市場規模的估計·預測,各疾病
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第6章 企業簡介

目錄
Product Code: GVR-1-68038-542-7

The global enteric disease testing market is expected to reach USD 4.2 billion by 2025 according to a new study by Grand View Research Inc. Increasing demand for rapid diagnosis in order to treat diseases such as cholera, and other diarrheal diseases, rise in the aging population accompanied with unhygienic living conditions and growing application of medical testing for enteric diseases are expected to drive the market over the forecast period.

The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease prevalence rate.Economic and environmental factors such as poor sanitation and rising population living below the poverty line with no access to hygienic food and water supply are attributed to growing incidence rate of the infections and thus propel the market growth.

According to database of Bill and Melinda Gate Foundation, enteric diseases were responsible for about 500,000 deaths each year and these are anticipated to increase further. The highest mortality rate was observed amongst people above 75 years of age followed by children under 5 year of age.

Strategic initiatives by healthcare federal bodies such as the WHO and UNICEF, to manage the disease fatality effectively are expected to assist market growth. These agencies are working towards promoting widespread testing of people for such infections by conducting awareness programmes and healthcare camps. They also fund local agencies in third world countries to limit the spread of these infections.

Further key findings from the study suggest:

  • Bacterial enteric disease testing market is expected to dominate the market in 2025 with revenue share of over 60.32% in 2016 due to higher occurrence of these infections. According to research conducted by Johns Hopkins Bloomberg School of Public Health, around four to six million people die annually due to bacterial infection induced diarrhea.
  • Parasitic enteric disease testing market is expected to register significant growth with CAGR of 1.9%. The WHO has estimated over 200 million people to be infected annually by parasites such as giardia lamblia, cryptosporidium and E. histolytica.
  • North American region is anticipated to contribute for 26.55% revenue in 2025, owing to rising geriatric population base, increasing number of immigrants, and rising patient awareness levels coupled with relatively higher healthcare expenditures in the region.
  • Asia Pacific region is projected to reach over USD 1.0 billion by registering lucrative growth rate in 2025. Government efforts in countries such as Japan, China, and India to increase awareness and promote higher testing are expected to drive the market over the forecast period.
  • Major market players are Alere Inc., Quest Diagnostics, Becton Dickinson & Company, bioMerieux, Bio-Rad Laboratories and Cepheid.
  • Industry players are constantly fueling the market with new product launches or upgrading the existing technology. In January 2015, Biomerica filed a patent application with the U.S. Patent and Trademark Office for a test used in detection of gastrointestinal disorder.
  • Apart from technology innovation, many industry players are collaborating to use each other's strength and are formulating strategic alliances in order to incur higher profits. For instance, in May 2017, Quest diagnostics announced collaboration with PeaceHealth to enhance the service through high value design and innovation.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope & assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

  • 2.1. Enteric Disease Testing - Industry Summary and Key Buying Criteria, 2014 - 2025

Chapter 3. Enteric Disease Testing Industry Outlook

  • 3.1. Enteric disease testing market segmentation
  • 3.2. Enteric disease testing market size and growth prospects, 2014-2025
  • 3.3. Enteric disease testing market dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Key opportunities prioritized
  • 3.5. Industry analysis - Porter's
  • 3.6. Enteric disease testing market PESTEL analysis, 2014

Chapter 4. Enteric Disease Testing Disease Type Outlook

  • 4.1. Enteric disease testing market share by disease type, 2014 & 2025
  • 4.2. Bacterial enteric disease market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.2.1. C. difficile
    • 4.2.2. Campylobacteriosis
    • 4.2.3. Cholera
    • 4.2.4. E.Coli
    • 4.2.5. H.Pylori
    • 4.2.6. Salmonellosis
    • 4.2.7. Shigellosis
  • 4.3. Viral enteric disease estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.3.1. Rotavirus
    • 4.3.2. Norovirus
  • 4.4. Parasitic enteric disease market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.4.1. Amebiasis
    • 4.4.2. Cryptosporidiosis
    • 4.4.3. Giardiasis

Chapter 5. Enteric Disease Testing Regional Outlook

  • 5.1. North America
    • 5.1.1. North America market, by disease type, 2014 - 2025 (USD Million)
  • 5.2. Europe
    • 5.2.1. Europe market, by disease type, 2014 - 2025 (USD Million)
  • 5.3. Asia Pacific
    • 5.3.1. Asia Pacific market, by disease type, 2014 - 2025 (USD Million)
  • 5.4. Latin America
    • 5.4.1. Latin America market, by disease type, 2014 - 2025 (USD Million)
  • 5.5. MEA
    • 5.5.1. MEA market, by disease type, 2014 - 2025 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Alere Inc.
    • 6.1.1. Company Overview
    • 6.1.2. Financial Performance
    • 6.1.3. Product Benchmarking
    • 6.1.4. Strategic Initiatives
  • 6.2. Becton, Dickinson & Company
    • 6.2.1. Company Overview
    • 6.2.2. Financial Performance
    • 6.2.3. Product Benchmarking
    • 6.2.4. Strategic Initiatives
  • 6.3. Biomerica Inc.
    • 6.3.1. Company Overview
    • 6.3.2. Financial Performance
    • 6.3.3. Product Benchmarking
    • 6.3.4. Strategic Initiatives
  • 6.4. bioMerieux
    • 6.4.1. Company Overview
    • 6.4.2. Financial Performance
    • 6.4.3. Product Benchmarking
    • 6.4.4. Strategic Initiatives
  • 6.5. Bio Rad Laboratories
    • 6.5.1. Company Overview
    • 6.5.2. Financial Performance
    • 6.5.3. Product Benchmarking
    • 6.5.4. Strategic Initiatives
  • 6.6. Cepheid
    • 6.6.1. Company Overview
    • 6.6.2. Financial Performance
    • 6.6.3. Product Benchmarking
    • 6.6.4. Strategic Initiatives
  • 6.7. Coris BioConcept
    • 6.7.1. Company Overview
    • 6.7.2. Financial Performance
    • 6.7.3. Product Benchmarking
    • 6.7.4. Strategic Initiatives
  • 6.8. DiaSorin
    • 6.8.1. Company Overview
    • 6.8.2. Financial Performance
    • 6.8.3. Product Benchmarking
    • 6.8.4. Strategic Initiatives
  • 6.9. Meridian BioSceinces
    • 6.9.1. Company Overview
    • 6.9.2. Financial Performance
    • 6.9.3. Product Benchmarking
    • 6.9.4. Strategic Initiatives
  • 6.10. Quest Diagnostics
    • 6.10.1. Company Overview
    • 6.10.2. Financial Performance
    • 6.10.3. Product Benchmarking
    • 6.10.4. Strategic Initiatives

List of Tables

  • 1. Enteric disease testing - Industry Snapshot
  • 2. Enteric disease testing market, by product, 2014 - 2025 (USD million)
  • 3. Enteric disease testing market , by region, 2014 - 2025 (USD million)
  • 4. Enteric disease testing market - Key market drivers analysis
  • 5. Enteric disease testing market - Key market restraints analysis
  • 6. North America Enteric disease testing market , by type, 2014 - 2025 (USD million)
  • 7. Europe enteric disease testing market , by type, 2014 - 2025 (USD million)
  • 8. Asia Pacific enteric disease testing market , by type, 2014 - 2025 (USD million)
  • 9. Latin America enteric disease testing market , by type, 2014 - 2025 (USD million)
  • 10. MEA enteric disease testing market , by type, 2014 - 2025 (USD million)

List of Figures

  • 1. Enteric disease testing market segmentation
  • 2. Global enteric disease testing market revenue, 2014 - 2025
  • 3. Enteric disease testing market dynamics
  • 4. Key Opportunities Prioritized
  • 5. Enteric disease testing market Analysis - Porter's
  • 6. Enteric disease testing market - PESTEL Analysis
  • 7. Global enteric disease testing market , by disease type, 2014 - 2025 (USD million)
  • 8. Bacterial enteric disease market, 2014 - 2025 (USD million)
  • 9. Viral enteric disease market, 2014 - 2025 (USD million)
  • 10. Parasitic enteric disease market, 2014 - 2025 (USD million)
  • 11. Global enteric disease testing market , by region, 2014 to 2025 (USD million)
  • 12. North America market, by disease type, 2014 to 2025 (USD million)
  • 13. Europe market, by disease type, 2014 to 2025 (USD million)
  • 14. Asia Pacific market, by disease type, 2014 to 2025 (USD million)
  • 15. Latin America market, by disease type, 2014 to 2025 (USD million)
  • 16. MEA market, by disease type, 2014 to 2025 (USD million)
Back to Top